Syndesi Therapeutics is developing novel modulators of the synaptic vesicle protein SV2A to address disorders of cognition.
Location: Belgium, Walloon Brabant, Ottignies-Louvain-la-Neuve
Member count: 11-50
Total raised: $20.826697M
Founded date: 2018
Investors 2
| Date | Name | Website |
| - | UCB Ventur... | ucbventure... |
| - | V-Bio Vent... | v-bio.vent... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 09.02.2018 | Series A | $20.826697... | - | finsmes.co... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 12.02.2018 | Term Sheet... | SETTLED Good morning, Term Sh... | - | - | fortune.co... |
| 09.02.2018 | Syndesi Th... | Syndesi Therapeutics, a Belgia... | Belgium | - | finsmes.co... |